How Cardiac Advanced Life Support Works in Cardiac Arrest

Cardiac advanced life support is the structured set of medical interventions performed when someone’s heart stops or enters a life-threatening rhythm, going well beyond basic CPR to include defibrillation, intravenous medications, advanced airway placement, and real-time physiological monitoring. In hospitals it is commonly called ACLS (Advanced Cardiovascular Life Support); in the field, paramedics follow similar protocols adapted for prehospital conditions. The goal sounds simple: restart the heart and keep the brain alive. In practice, every component of the process is the subject of ongoing research, and some long-held assumptions have shifted dramatically in the past decade.

Why CPR Quality Drives Everything Else

Before any drug or shock can do its job, blood has to be flowing. Chest compressions generate a fraction of normal cardiac output, and the key measurement researchers track is coronary perfusion pressure, which reflects how much blood is reaching the heart muscle itself during CPR. A landmark study showed that patients who regained a pulse had a peak coronary perfusion pressure averaging about 26 mmHg, while those who did not averaged only about 8 mmHg. No patient in that study whose coronary perfusion pressure stayed below 15 mmHg was successfully resuscitated.¹ Later work confirmed that both the peak pressure and the cumulative pressure over time independently predict whether a patient’s heart restarts.²

This is why guidelines are emphatic about minimizing pauses in compressions. Even a few seconds of interruption lets the pressure you have built up collapse, and it takes multiple compression cycles to build it back. Every intervention during a cardiac arrest, from rhythm checks to intubation to ultrasound, is weighed against this cost. If it interrupts compressions for too long, it may do more harm than good regardless of the information it provides.

Defibrillation and What Happens When the First Shock Fails

For ventricular fibrillation and pulseless ventricular tachycardia, electrical defibrillation remains the single most effective treatment. Standard protocol calls for a shock, followed by two minutes of CPR, then another rhythm check and another shock if needed. Most patients who respond will do so within the first few shocks. The harder question is what to do when a patient stays in a shockable rhythm after multiple standard attempts.

A recent randomized trial tested two alternatives for shock-resistant ventricular fibrillation: double sequential external defibrillation (using two defibrillators to deliver overlapping shocks) and vector-change defibrillation (repositioning the pads to a different axis). Survival to hospital discharge roughly doubled with double sequential defibrillation compared to standard shocks, and good neurological outcomes were significantly better as well. Vector-change defibrillation also showed a survival advantage, though the neurological benefit was less certain.³ An earlier systematic review, however, found no clear differences between double sequential defibrillation and standard approaches across the then-available evidence, which consisted mostly of observational studies.⁴ The newer randomized trial carries more weight, but the technique requires two defibrillators on scene, which is not standard on most ambulances. It is increasingly being adopted at centers that deal frequently with refractory arrests.

Epinephrine and the Timing Problem

Epinephrine (adrenaline) is the cornerstone drug of ACLS, given intravenously every three to five minutes during a cardiac arrest. It constricts blood vessels everywhere except the heart and brain, redirecting whatever blood flow CPR generates toward the organs that matter most. The drug reliably increases the odds of getting a pulse back. Whether it improves long-term survival with a functioning brain is far less clear, and this tension has driven some of the most debated research in resuscitation science.

What does seem to matter is speed. In patients with non-shockable rhythms (the arrests that tend to have worse outcomes), each minute of delay from the arrival of emergency services to the first dose of epinephrine was associated with roughly a 4% drop in the odds of survival.⁵ A secondary analysis of the large Paramedic 2 trial found that while the rate of getting a pulse back declined over time for everyone, it declined faster in the placebo group than in the epinephrine group, suggesting that the drug’s benefit for restarting the heart grows relative to placebo as time passes. Longer-term survival and neurological outcomes, though, did not differ between the epinephrine and placebo groups regardless of timing.⁶ The upshot: give epinephrine early if you are going to give it, especially for non-shockable rhythms, but do not expect it alone to guarantee a good outcome.⁷

Amiodarone Versus Lidocaine

When ventricular fibrillation persists after multiple shocks, antiarrhythmic drugs enter the picture. For years, amiodarone was the go-to choice. An early trial found that patients given amiodarone for shock-resistant ventricular fibrillation survived to hospital admission at nearly double the rate of those given lidocaine.⁸ That finding shaped guidelines for over a decade.

The picture has gotten muddier since then. A large randomized trial comparing amiodarone, lidocaine, and placebo for out-of-hospital cardiac arrest found no statistically significant difference in survival to discharge among the three groups, and neurological outcomes were similar.⁹ Meanwhile, a study specifically looking at in-hospital cardiac arrests found that lidocaine was actually associated with higher rates of return of spontaneous circulation, survival to discharge, and favorable neurological outcomes compared with amiodarone.¹⁰ The setting may matter: in-hospital arrests tend to be witnessed earlier, and the drug pharmacology may play out differently when given sooner. Current guidelines still list both as options, and the honest state of knowledge is that neither drug has shown a clear survival-to-discharge advantage over placebo in the largest out-of-hospital trial.

Airway Management During Cardiac Arrest

ACLS protocols call for some form of advanced airway management, but which approach works best has been surprisingly hard to settle. The two main options are endotracheal intubation, which involves passing a tube through the vocal cords into the windpipe, and supraglottic airway devices, which sit above the vocal cords and are faster to place with less training. Multiple randomized trials and observational studies have compared the two during cardiac arrest, and the consistent finding is that outcomes are similar.

The AIRWAYS-2 trial, one of the largest, found no difference in neurological outcomes at 30 days between a supraglottic device and intubation when used by paramedics.¹¹ A cluster randomized trial in Taipei found essentially identical rates of sustained return of spontaneous circulation, survival to discharge, and favorable neurological outcomes between the two strategies.¹² An earlier observational study showed the same result: favorable neurological outcome at 3.6% in both groups.¹³

The practical implication is that a quickly and correctly placed supraglottic device is at least as good as intubation during cardiac arrest, and it causes fewer interruptions in chest compressions. Intubation still has a role, particularly in the hospital where experienced operators are available, but the data do not support delaying compressions to attempt a difficult intubation in the field.

Real-Time Monitoring With Capnography and Ultrasound

One of the most useful tools during ACLS is capnography, which measures the amount of carbon dioxide in exhaled breath. Because CO2 only reaches the lungs if blood is circulating through them, the reading serves as a real-time proxy for how effective chest compressions are. A sudden spike in the reading often signals that the heart has restarted even before anyone checks a pulse. In pediatric cardiac arrests, patients whose average end-tidal CO2 stayed at or above 20 mmHg were significantly more likely to survive to discharge than those with lower values.¹⁴ A systematic review in adults found that CO2 values during CPR were consistently higher in patients who eventually regained a pulse, and very low initial readings were strongly predictive of death, though the exact cutoff varied across studies.¹⁵ Capnography also provides definitive confirmation that an endotracheal tube is in the right place.¹⁶

Point-of-care ultrasound is a newer addition. A trained operator can use it during the brief pause for a rhythm check to look for treatable causes of the arrest, such as a blood clot in the lungs or fluid around the heart. It can also detect cardiac wall motion, which may help distinguish a truly pulseless patient from one whose blood pressure is too low for a pulse to be felt. A crossover study found that ultrasound detected a pulse on the first attempt more reliably than manual palpation, with similar detection times.¹⁷ The main concern with ultrasound is that it can extend pauses in chest compressions if used carelessly. Guidelines stress that any scan should fit within the 10-second window of a pulse check and should not delay resumption of CPR.¹⁸

Mechanical CPR Devices and Extracorporeal CPR

Mechanical chest compression devices, like the LUCAS system, use a piston or band to deliver compressions at a consistent rate and depth without tiring. They are appealing in situations where manual compressions are difficult: during ambulance transport, in a cardiac catheterization lab, or when few rescuers are available. Despite this theoretical advantage, outcomes have been stubbornly similar to manual CPR. A large pragmatic trial found no difference in 30-day survival between mechanical and manual compressions.¹⁹ A meta-analysis confirmed no significant differences in return of spontaneous circulation, hospital survival, or long-term survival, and actually found that manual compressions were associated with slightly better neurological outcomes.²⁰

A more aggressive technology is extracorporeal CPR, in which a patient is placed on a heart-lung bypass machine during the arrest itself. The machine drains blood from a large vein, oxygenates it externally, and pumps it back into an artery, essentially replacing the heart’s function entirely. This approach is resource-intensive and requires a specialized team, but for refractory ventricular fibrillation it has shown promise. A phase 2 trial in London found that extracorporeal CPR significantly improved survival to discharge compared with standard ACLS in patients with refractory ventricular fibrillation.²¹ A larger trial, however, found no statistically significant difference: about 20% of patients in the extracorporeal group had a good neurological outcome at 30 days versus 16% in the conventional group.²² Timing and logistics are major obstacles. A feasibility trial that tested expedited transport to get patients onto the machine faster found that none of the enrolled patients in either arm survived with a good neurological outcome, underscoring how difficult it is to move fast enough.²³

What Happens After the Heart Restarts

Getting a pulse back is only part of the battle. A large proportion of deaths after cardiac arrest occur in the hours and days that follow, driven by a cascade of whole-body injury from the period of no blood flow and then the sudden return of circulation. This post-cardiac arrest syndrome involves inflammation, organ damage, and brain injury that require careful ICU management.²⁴

For years, cooling patients to 32–34°C after cardiac arrest was considered standard care, based on earlier trials suggesting it improved brain outcomes. That consensus has eroded. The large TTM2 trial found that cooling to 33°C provided no benefit over simply maintaining normal body temperature; mortality and neurological outcomes were essentially identical, and the cooled group had more heart rhythm complications.²⁵ A systematic review and meta-analysis corroborated this, finding no mortality benefit or improvement in neurological outcomes with targeted hypothermia, alongside a higher rate of arrhythmias in the cooled group.²⁶ For patients with non-shockable rhythms specifically, a meta-analysis similarly found no difference in death or functional outcomes between hypothermia and normothermia.²⁷ Current practice has shifted toward actively preventing fever rather than aggressively cooling.

Another key post-arrest intervention is early coronary angiography, the procedure where dye is injected into the heart’s arteries to look for blockages. This is straightforward when the patient’s ECG shows an ST-elevation pattern suggesting a fresh heart attack. But even in patients without that pattern, a blocked coronary artery turns out to be the cause of the arrest in a substantial minority. One registry found a culprit coronary lesion requiring intervention in nearly a third of cardiac arrest patients without ST-elevation, and treating it was associated with roughly double the rate of favorable outcomes.²⁸ A meta-analysis of eight studies confirmed that early angiography in these patients was associated with lower short-term and long-term mortality and improved neurological outcomes.²⁹

Oxygen management after resuscitation also matters. While high-flow oxygen is instinctive during an emergency, prolonged exposure to very high oxygen levels in the blood after return of circulation appears to harm the brain. A prospective multicenter study found that hyperoxia was independently associated with worse neurological outcomes, and each additional hour of exposure increased the risk by about 3%. The association began at arterial oxygen levels above 300 mmHg.³⁰ A study in patients who underwent extracorporeal CPR found that extreme hyperoxia, but not moderate hyperoxia, was linked to significantly worse 30-day neurological outcomes.³¹ The takeaway for post-arrest care is to titrate oxygen down to normal levels once monitoring is in place, rather than flooding the patient with it.

Predicting Neurological Recovery

One of the most difficult questions in post-arrest care is predicting whether a patient who remains comatose will wake up with meaningful brain function. Getting this wrong in either direction has profound consequences: premature withdrawal of care can end a life that would have recovered, while indefinitely prolonging treatment in a patient with devastating brain injury is its own form of harm. Current guidelines strongly recommend that prognostication be multimodal, meaning it should draw on clinical examination, brain imaging, electrical brain activity recordings, and blood biomarkers together, and should never rely on any single test or finding.³² Most centers wait at least 72 hours after the arrest, and longer if the patient was cooled, before making formal prognostic assessments, because sedation and temperature management can mimic the appearance of severe brain injury.

In-Hospital Versus Out-of-Hospital Arrest

Where the arrest happens makes a dramatic difference in raw survival numbers, but the reasons are more about circumstance than biology. A large national study found that in-hospital cardiac arrest was associated with roughly 40% higher 30-day survival compared to out-of-hospital arrest in unadjusted analysis. Once researchers accounted for cardiac arrest characteristics like whether the arrest was witnessed and what the initial rhythm was, the survival difference essentially disappeared.³³ In other words, the advantage of arresting in a hospital comes from being monitored and witnessed, from having a team seconds away rather than minutes away, and from more often presenting with a shockable rhythm, not from some fundamental biological difference between the two populations.

When to Stop Resuscitation

Knowing when to stop CPR is one of the most ethically fraught decisions in emergency medicine. Termination-of-resuscitation rules have been developed to help paramedics identify patients with essentially no chance of survival, avoiding futile transport and allowing a dignified end in the field. The most widely studied is the universal termination of resuscitation rule, which considers factors like whether the arrest was witnessed, whether bystander CPR was performed, and whether a shockable rhythm was ever present.

In its initial validation, the rule recommended stopping efforts in 776 patients; only 4 of them survived, giving it a positive predictive value for death of 99.5%. If implemented, it would have reduced emergency transport rates from 100% to about 37%.³⁴ An external validation in British Columbia found a somewhat higher false-positive rate of 2.1% when the rule was applied at 6 minutes, meaning about 2 in 100 patients the rule would have recommended stopping on actually survived to discharge. At 30 minutes, specificity was nearly perfect but sensitivity dropped, meaning the rule missed many non-survivors and was less useful for identifying them.³⁵ A systematic review and meta-analysis noted that even the best-performing rule may not be suitable in systems where baseline survival rates exceed about 8%, because higher-performing systems will inherently have more survivors among the patients the rule flags for termination.³⁶

Dispatcher-Guided CPR and the Role of Bystanders

ACLS does not start when the ambulance arrives. For out-of-hospital arrests, the chain often begins with a 911 dispatcher coaching a bystander through CPR by phone. Compression-only instructions have been heavily promoted in recent years because they are simpler and faster to teach over the phone, but the evidence suggests that including rescue breaths may still matter. A large population-based study in Japan found that dispatcher-guided conventional CPR (compressions plus ventilations) was associated with about 30% higher odds of a favorable neurological outcome at one month compared to compression-only instructions.³⁷ This does not mean compression-only CPR is wrong; for an untrained bystander who is hesitant to perform mouth-to-mouth, compressions alone are far better than doing nothing. But when the dispatcher can coach ventilations too, the evidence supports doing so.

Team Dynamics and Simulation Training

A cardiac arrest resuscitation involves multiple people performing different tasks simultaneously: compressions, airway management, medication preparation, rhythm analysis, documentation, and communication with the team leader. Breakdowns in coordination are a well-documented source of errors. Closed-loop communication, where an order is acknowledged and confirmed before being carried out, reduces the chance that a drug is given at the wrong dose or a task is duplicated or missed. Simulation-based training, where teams run through realistic arrest scenarios on mannequins, has been shown to measurably improve self-reported competency in communication, leadership, and team coordination skills among emergency teams.³⁸ Many hospitals now mandate periodic simulation sessions, treating resuscitation as a team sport that requires practice rather than a procedure that can be executed from memory alone.

Pediatric Cardiac Arrest

Children who suffer out-of-hospital cardiac arrest present different challenges than adults. Their arrests are more commonly caused by respiratory failure or drowning rather than primary heart problems, which means the initial rhythm is usually non-shockable. Despite these differences, children actually had better adjusted odds of one-month survival than adults in a large Japanese study, and were more than twice as likely to survive with a favorable neurological outcome.³⁹ The reasons likely include younger, more resilient brains and hearts, and the fact that pediatric arrests from respiratory causes may respond better to ventilation-focused resuscitation. Pediatric ACLS algorithms share the same skeleton as adult protocols but adjust drug doses for weight, use smaller equipment, and emphasize oxygenation and ventilation earlier in the sequence.